News
Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration and a critic of the ...
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure. A ...
A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the ...
Sarepta Therapeutics’ stock was soaring Tuesday after the FDA recommended lifting the pause on the company’s Duchenne ...
Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.
Sarepta Therapeutics shares snapped a three-day losing streak on Tuesday, as analysts said resumption of U.S. shipments for ...
The FDA investigated the death of a boy in Brazil on Elevidys and concluded it was unrelated to the treatment.
1d
MedPage Today on MSNShipments of Duchenne Gene Therapy to Resume After FDA Review of Patient DeathSarepta's therapy has been under scrutiny from regulators after two teenage boys died earlier this year from acute liver ...
Sarepta Therapeutics said it will resume shipments of its gene therapy Elevidys® (delandistrogene moxeparvovec-rokl) “imminently” to ambulant patients with Duchenne muscular dystrophy (DMD), ending a ...
Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping ...
The FDA investigated the death of a boy in Brazil on Elevidys and concluded it was unrelated to the treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results